Taken together, our results show that CD40L blockade has an unsuspected effect on the lymphopenia-induced proliferation of donor CD4+ T cells but does not prevent their ability to promote the CD8+ T cell-mediated onset of disease. This evidence concerns the gene CD8A and lymphopenia.